Search Results - "Nast, A."

The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update by Maurer, M., Magerl, M., Ansotegui, I., Aygören‐Pürsün, E., Betschel, S., Bork, K., Bowen, T., Balle Boysen, H., Farkas, H., Grumach, A. S., Hide, M., Katelaris, C., Lockey, R., Longhurst, H., Lumry, W. R., Martinez‐Saguer, I., Moldovan, D., Nast, A., Pawankar, R., Potter, P., Riedl, M., Ritchie, B., Rosenwasser, L., Sánchez‐Borges, M., Zhi, Y., Zuraw, B., Craig, T.

“…Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and appropriate therapy are essential. This update and revision of the global…”
Get full text

European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy by Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., Bieber, T., Brough, H.A., Calzavara Pinton, P., Christen‐Zäch, S., Deleuran, M., Dittmann, M., Dressler, C., Fink‐Wagner, A.H., Fosse, N., Gáspár, K., Gerbens, L., Gieler, U., Girolomoni, G., Gregoriou, S., Mortz, C.G., Nast, A., Nygaard, U., Redding, M., Rehbinder, E.M., Ring, J., Rossi, M., Serra‐Baldrich, E., Simon, D., Szalai, Z.Z., Szepietowski, J.C., Torrelo, A., Werfel, T., Flohr, C.

“…The evidence‐ and consensus‐based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development…”
Get full text

The natural history of actinic keratosis: a systematic review by Werner, R.N., Sammain, A., Erdmann, R., Hartmann, V., Stockfleth, E., Nast, A.

“…Summary Knowledge about the development of untreated actinic keratosis (AK) and risk of progression into squamous cell carcinoma (SCC) is important. Therefore,…”
Get full text

European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations by Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., Bieber, T., Brough, H.A., Calzavara Pinton, P., Christen‐Zäch, S., Deleuran, M., Dittmann, M., Dressler, C., Fink‐Wagner, A.H., Fosse, N., Gáspár, K., Gerbens, L., Gieler, U., Girolomoni, G., Gregoriou, S., Mortz, C.G., Nast, A., Nygaard, U., Redding, M., Rehbinder, E.M., Ring, J., Rossi, M., Serra‐Baldrich, E., Simon, D., Szalai, Z.Z., Szepietowski, J.C., Torrelo, A., Werfel, T., Flohr, C.

“…The evidence‐ and consensus‐based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development…”
Get full text

Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials by Schmitt, J., Rosumeck, S., Thomaschewski, G., Sporbeck, B., Haufe, E., Nast, A.

“…Summary Dermatologists may choose from various conventional and biological systemic agents to treat patients with moderate‐to‐severe psoriasis. We set out to…”
Get full text

Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version by Kanti, V., Messenger, A., Dobos, G., Reygagne, P., Finner, A., Blumeyer, A., Trakatelli, M., Tosti, A., Marmol, V., Piraccini, B.M., Nast, A., Blume‐Peytavi, U.

“…Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia usually develop during…”
Get full text

Definition of treatment goals for moderate to severe psoriasis: a European consensus by Mrowietz, U, Kragballe, K, Reich, K, Spuls, P, Griffiths, C. E. M, Nast, A, Franke, J, Antoniou, C, Arenberger, P, Balieva, F, Bylaite, M, Correia, O, Daudén, E, Gisondi, P, Iversen, L, Kemény, L, Lahfa, M, Nijsten, T, Rantanen, T, Reich, A, Rosenbach, T, Segaert, S, Smith, C, Talme, T, Volc-Platzer, B, Yawalkar, N

“…Patients with moderate to severe psoriasis are undertreated. To solve this persistent problem, the consensus programme was performed to define goals for…”
Get full text

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC by Nast, A., Gisondi, P., Ormerod, A.D., Saiag, P., Smith, C., Spuls, P.I., Arenberger, P., Bachelez, H., Barker, J., Dauden, E., de Jong, E.M., Feist, E., Jacobs, A., Jobling, R., Kemény, L., Maccarone, M., Mrowietz, U., Papp, K.A., Paul, C., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., van de Kerkhof, P., Werner, R.N., Yawalkar, N.

Get full text

Rifampicin alone may be enough: is it time to abandon the classic oral clindamycin–rifampicin combination for hidradenitis suppurativa? by Albrecht, J., Barbaric, J., Nast, A.

“…Linked Article: Albrecht et al. Br J Dermatol 2019; 180:749–755…”
Get full text

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update by Zuberbier, T, Aberer, W, Asero, R, Bindslev-Jensen, C, Brzoza, Z, Canonica, G W, Church, M K, Ensina, L F, Giménez-Arnau, A, Godse, K, Gonçalo, M, Grattan, C, Hebert, J, Hide, M, Kaplan, A, Kapp, A, Abdul Latiff, A H, Mathelier-Fusade, P, Metz, M, Nast, A, Saini, S S, Sánchez-Borges, M, Schmid-Grendelmeier, P, Simons, F E R, Staubach, P, Sussman, G, Toubi, E, Vena, G A, Wedi, B, Zhu, X J, Maurer, M

“…This guideline is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE)…”
Get full text

A critical eye on registry data in psoriasis by Egeberg, A., Nast, A.

Get full text

A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis by Mrowietz, U., de Jong, E.M.G.J., Kragballe, K., Langley, R., Nast, A., Puig, L., Reich, K., Schmitt, J., Warren, R.B.

“…Background There is limited information on systemic and biological treatment optimization and transitioning in routine clinical practice. Objective To provide…”
Get full text

European consensus‐based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment by Werner, R.N., Nikkels, A.F., Marinović, B., Schäfer, M., Czarnecka‐Operacz, M., Agius, A.M., Bata‐Csörgő, Z., Breuer, J., Girolomoni, G., Gross, G.E., Langan, S., Lapid‐Gortzak, R., Lesser, T.H., Pleyer, U., Sellner, J., Verjans, G.M., Wutzler, P., Dressler, C., Erdmann, R., Rosumeck, S., Nast, A.

“…Herpes zoster (HZ, shingles) is a frequent medical condition which may severely impact the quality of life of affected patients. Different therapeutic…”
Get full text

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations by Nast, A., Smith, C., Spuls, P.I., Avila Valle, G., Bata‐Csörgö, Z., Boonen, H., De Jong, E., Garcia‐Doval, I., Gisondi, P., Kaur‐Knudsen, D., Mahil, S., Mälkönen, T., Maul, J.T., Mburu, S., Mrowietz, U., Reich, K., Remenyik, E., Rønholt, K.M., Sator, P.G., Schmitt‐Egenolf, M., Sikora, M., Strömer, K., Sundnes, O., Trigos, D., Van Der Kraaij, G., Yawalkar, N., Dressler, C.

“…This evidence‐ and consensus‐based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement…”
Get full text

The value and pitfalls of biologics registries for psoriasis by Egeberg, A., Nast, A.

“…Linked Article: Dávila‐Seijo et al. Br J Dermatol 2018; 178:300–301…”
Get full text

Incidences of different cancer types in dermatomyositis, polymyositis and dermatopolymyositis: results of a registry analysis by Zidane, M., Dressler, C., Nast, A., Egeberg, A.

Get full text

European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology by Ioannides, D., Vakirlis, E., Kemeny, L., Marinovic, B., Massone, C., Murphy, R., Nast, A., Ronnevig, J., Ruzicka, T., Cooper, S.M., Trüeb, R.M., Pujol Vallverdú, R.M., Wolf, R., Neumann, M.

“…Lichen planus (LP) is a chronic inflammatory and immune‐mediated disease that affects the skin, hair, nails and mucous membranes. Although there is a broad…”
Get full text

European Evidence-based (S3) Guidelines for the Treatment of Acne by Nast, A., Dréno, B., Bettoli, V., Degitz, K., Erdmann, R., Finlay, A. Y., Ganceviciene, R., Haedersdal, M., Layton, A., López-Estebaranz, J.L., Ochsendorf, F., Oprica, C., Rosumeck, S., Rzany, B., Sammain, A., Simonart, T., Veien, N.K., Živković, M.V., Zouboulis, C.C., Gollnick, H.

Get full text

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations by Nast, A., Smith, C., Spuls, P.I., Avila Valle, G., Bata‐Csörgö, Z., Boonen, H., De Jong, E., Garcia‐Doval, I., Gisondi, P., Kaur‐Knudsen, D., Mahil, S., Mälkönen, T., Maul, J.T., Mburu, S., Mrowietz, U., Reich, K., Remenyik, E., Rønholt, K.M., Sator, P.G., Schmitt‐Egenolf, M., Sikora, M., Strömer, K., Sundnes, O., Trigos, D., Van Der Kraaij, G., Yawalkar, N., Dressler, C.

“…This evidence‐ and consensus‐based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement…”
Get full text

Efficacy and safety of systemic treatments in psoriatic arthritis: a systematic review, meta‐analysis and GRADE evaluation by Dressler, C., Eisert, L., Pham, P.A., Nast, A.

“…Twenty per cent of patients with plaque psoriasis also have psoriatic arthritis – a disease affecting joints and entheses. Different treatment options exist…”
Get full text